AlphaGenome has arrived to decode the 98% of our DNA once dismissed as 'junk,' offering a unified view of how genetic mutations impact molecular mechanisms. As this predictive power becomes accessible via open APIs, we face a critical choice between revolutionary medical equity and the risks of unchecked genetic surveillance.